These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21768942)

  • 1. Two-year Experience with Buprenorphine-naloxone (Suboxone) for Maintenance Treatment of Opioid Dependence Within a Private Practice Setting.
    Finch JW; Kamien JB; Amass L
    J Addict Med; 2007 Jun; 1(2):104-10. PubMed ID: 21768942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early experience with Suboxone maintenance therapy in Hungary.
    Demetrovics Z; Farkas J; Csorba J; Németh A; Mervó B; Szemelyácz J; Fleischmann E; Kassai-Farkas A; Petke Z; Oroján T; Rózsa S; Rigó P; Funk S; Kapitány M; Kollár A; Rácz J
    Neuropsychopharmacol Hung; 2009 Dec; 11(4):249-57. PubMed ID: 20150662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence.
    Bell J; Byron G; Gibson A; Morris A
    Drug Alcohol Rev; 2004 Sep; 23(3):311-7. PubMed ID: 15370011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboxone (buprenorphine/naloxone) toxicity in pediatric patients: a case report.
    Schwarz KA; Cantrell FL; Vohra RB; Clark RF
    Pediatr Emerg Care; 2007 Sep; 23(9):651-2. PubMed ID: 17876257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
    Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
    J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Sullivan LE; Chawarski M; O'Connor PG; Schottenfeld RS; Fiellin DA
    Drug Alcohol Depend; 2005 Jul; 79(1):113-6. PubMed ID: 15943950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of buprenorphine maintenance in office-based practice.
    Magura S; Lee SJ; Salsitz EA; Kolodny A; Whitley SD; Taubes T; Seewald R; Joseph H; Kayman DJ; Fong C; Marsch LA; Rosenblum A
    J Addict Dis; 2007; 26(2):13-23. PubMed ID: 17594994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone).
    Welsh C; Sherman SG; Tobin KE
    Addiction; 2008 Jul; 103(7):1226-8. PubMed ID: 18554353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians.
    Johanson CE; Arfken CL; di Menza S; Schuster CR
    Drug Alcohol Depend; 2012 Jan; 120(1-3):190-5. PubMed ID: 21862241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion and diversion of suboxone: an exploration of illicit street opioid selling.
    Furst RT
    J Addict Dis; 2014; 33(3):177-86. PubMed ID: 25115236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine Outpatient Outcomes Project: can Suboxone be a viable outpatient option for heroin addiction?
    Sittambalam CD; Vij R; Ferguson RP
    J Community Hosp Intern Med Perspect; 2014; 4(2):. PubMed ID: 24765257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine: a primer for emergency physicians.
    Sporer KA
    Ann Emerg Med; 2004 May; 43(5):580-4. PubMed ID: 15111917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Office-based buprenorphine treatment for opioid-dependent patients.
    McCance-Katz EF
    Harv Rev Psychiatry; 2004; 12(6):321-38. PubMed ID: 15764468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.